Structural determinants for binding, Activation, And functional selectivity of the angiotensin AT1 receptor

Journal of Molecular Endocrinology

Volumn 53, Issue 2, 2014, Pages R71-R92

  Balakumar, Pitchai ^a   Jagadeesh, Gowraganahalli ^b  

^a AIMST UNIVERSITY   (Malaysia)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Angiotensin II; AT1 receptor; B arrestin; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ARGININE; AZILSARTAN; CANDESARTAN; CYSTEINE; DISULFIDE; EPROSARTAN; GUANINE NUCLEOTIDE BINDING PROTEIN; HISTIDINE; IRBESARTAN; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OLMESARTAN; PHENYLALANINE; PROLINE; TELMISARTAN; TYROSINE; UNCLASSIFIED DRUG; VALIN; VALINE; VALSARTAN; AMINO ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; LIGAND; PROTEIN BINDING;

AMINO TERMINAL SEQUENCE; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; RECEPTOR BINDING; REVIEW; SITE DIRECTED MUTAGENESIS; AGONISTS; ANIMAL; BINDING SITE; CHEMISTRY; GENETICS; HUMAN; METABOLISM; PROTEIN DOMAIN; SIGNAL TRANSDUCTION;

AMINO ACIDS; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BINDING SITES; HUMANS; LIGANDS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECEPTOR, ANGIOTENSIN, TYPE 1; SIGNAL TRANSDUCTION;

EID: 84907996233     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-14-0125     Document Type: Review

References (124)

1. Akazawa H, Yano M, Yabumoto C, Kudo-Sakamoto Y & Komuro I 2013 Angiotensin II type 1 and type 2 receptor-induced cell signaling. Current Pharmaceutical Design 19 2988-2995. (doi:10.2174/1381612811319170003)
2. Ali MS, Sayeski PP, Dirksen LB, Hayzer DJ, Marrero MB & Bernstein KE 1997 Dependence on the motif YIPP for the physical association of Jak2 kinase with the intracellular carboxyl tail of the angiotensin II AT1 receptor. Journal of Biological Chemistry 272 23382-23388. (doi:10.1074/jbc.272.37.23382)
3. Audet M & Bouvier M 2012 Restructuring G-protein-coupled receptor activation. Cell 151 14-23. (doi:10.1016/j.cell.2012.09.003)
4. Balakumar P & Jagadeesh G 2014 A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology. Cellular Signalling 26 2147-2160. (doi:10.1016/j.cellsig.2014.06.011)
5. Balakumar P & Mahadevan N 2011 Multifaceted cardiac signal transduction mediated by G protein-coupled receptors: potential target sites where an unambiguous attention is needed for exploring new drugs for cardiovascular disorders. Biomedicine & Aging Pathology 1 197-202. (doi:10.1016/j.biomag.2011.04.004)
6. Balakumar P, Bishnoi HK & Mahadevan N 2012 Telmisartan in the management of diabetic nephropathy: a contemporary view. Current Diabetes Reviews 8 183-190. (doi:10.2174/157339912800563972)
7. Baleanu-Gogonea C & Karnik SS 2006 Model of the whole rat AT1 receptor and the ligand-binding site. Journal of Molecular Modeling 12 325-337. (doi:10.1007/s00894-005-0049-z)
8. Balmforth AJ, Lee AJ, Warburton P, Donnelly D & Ball SG 1997 The conformational change responsible for the AT1 receptor activation is dependent upon two juxtaposed asparagine residues on transmembrane helices III and VII. Journal of Biological Chemistry 272 4245-4251. (doi:10.1074/jbc.272.7.4245)
9. Bergsma DJ, Ellis C, Nuthulaganti PR, Nambi P, Scaife K, Kumar C & Aiyar N 1993 Isolation and expression of a novel angiotensin II receptor from Xenopus Iaevis heart. Molecular Pharmacology 44 277-284.
10. Bihoreau C, Monnot C, Davies E, Teutsch B, Bernstein KE, Corvol P & Clauser E 1993 Mutation of Asp74 of the rat angiotensin II receptor confers changes in antagonist affinities and abolishes G-protein coupling. PNAS 90 5133-5137. (doi:10.1073/pnas.90.11.5133)
11. Boucard AA, Wilkes BC, Laporte SA, Escher E, Guillemette G & Leduc R 2000 Photolabeling identifies position 172 of the human AT1 receptor as a ligand contact point: receptor-bound angiotensin II adopts an extended structure. Biochemistry 39 9662-9670. (doi:10.1021/bi000597v)
12. Boucard AA, Roy M, Beaulieu ME, Lavigne P, Escher E, Guillemette G & Leduc R 2003 Constitutive activation of the angiotensin II type 1 receptor alters the spatial proximity of transmembrane 7 to the ligand-binding pocket. Journal of Biological Chemistry 278 36628-36636. (doi:10.1074/jbc.M305952200)
13. Chaki S, Guo D-F, Yamano Y, Ohyama K, Tani M, Mizukoshi M, Shirai H & Inagami T 1994 Role of carboxyl tail of the rat angiotensin II type 1A receptor in agonist-induced internalization of the receptor. Kidney International 46 1492-1495. (doi:10.1038/ki.1994.427)
14. Cianchetti S, Del Fiorentino A, Colognato R, Di Stefano R, Franzoni F & Pedrinelli R 2008 Anti-inflammatory and anti-oxidant properties of telmisartan in cultured human umbilical vein endothelial cells. Atherosclerosis 198 22-28. (doi:10.1016/j.atherosclerosis.2007.09.013)
15. Claus M, Jaeschke H, Kleinau G, Neumann S, Krause G & Paschke R 2005 A hydrophobic cluster in the center of the third extracellular loop is important for thyrotropin receptor signaling. Endocrinology 146 5197-5203. (doi:10.1210/en.2005-0713)
16. Conchon S, Peltier N, Corvol P & Clauser E 1998 A noninternalized nondesensitized truncated AT1A receptor transduces an amplified ANGII signal. American Journal of Physiology. Endocrinology and Metabolism 274 E336-E345.
17. Correa SA, França LP, Costa-Neto CM, Oliveira L, Paiva AC & Shimuta SI 2002 Relevant role of Leu265 in helix VI of the angiotensin AT1 receptor in agonist binding and activity. Canadian Journal of Physiology and Pharmacology 80 426-430. (doi:10.1139/y02-046)
18. Costa-Neto CM, Miyakawa AA, Oliveira L, Hjorth SA, Schwartz TW & Paiva ACM 2000 Mutational analysis of the interaction of N-and C-terminal ends of angiotensin II with the AT1 receptor. British Journal of Pharmacology 130 1263-1268. (doi:10.1038/sj.bjp.0703430)
19. Décaillot FM, Befort K, Filliol D, Yue S, Walker P & Kieffer BL 2003 Opioid receptor random mutagenesis reveals a mechanism for G proteincoupled receptor activation. Nature Structural Biology 10 629-636. (doi:10.1038/nsb950)
20. Doan TN, Ali MS & Bernstein KE 2001 Tyrosine kinase activation by angiotensin II receptor in the absence of calcium signaling. Journal of Biological Chemistry 276 20954-20958. (doi:10.1074/jbc.C100199200)
21. Feng YH & Karnik SS 1999 Role of transmembrane helix IV in G-protein specificity of the angiotensin II type 1 receptor. Journal of Biological Chemistry 274 35546-35552. (doi:10.1074/jbc.274.50.35546)
22. Feng YH, Noda K, Saad Y, Liu XP, Husain A& Karnik SS 1995 The docking of Arg2 of angiotensin II with Asp281 of AT1 receptor is essential for full agonism. Journal of Biological Chemistry 270 12846-12850. (doi:10.1074/jbc.270.21.12846)
23. Feng YH, Miura S, Husain A & Karnik SS 1998 Mechanism of constitutive activation of the AT1 receptor: influence of the size of the agonist switch binding residue Asn111. Biochemistry 37 15791-15798. (doi:10.1021/bi980863t)
24. Fierens FL, Vanderheyden PM, Gáborik Z, Minh TL, Backer JP, Hunyady L, Ijzerman A & Vauquelin G 2000 Lys(199) mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non-peptide antagonists. Journal of the Renin-Angiotensin-Aldosterone System 1 283-288.
25. Fillion D, Lemieux G, Basambombo L.I., Lavigne P, Guillemette G, Leduc R & Escher E 2010 The amino-terminus of angiotensin II contacts several ectodomains of the angiotensin II receptor AT1. Journal of Medicinal Chemistry 53 2063-2075. (doi:10.1021/jm9015747)
26. Fillion D, Cabana J, Guillemette G, Leduc R, Lavigne P & Escher E 2013 Structure of the human angiotensin II type 1 (AT1) receptor bound to angiotensin II from multiple chemoselective photoprobe contacts reveals a unique peptide binding mode. Journal of Biological Chemistry 288 8187-8197. (doi:10.1074/jbc.M112.442053)
27. Fong TM, Huang RR & Strader CD 1992 Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor. Journal of Biological Chemistry 267 25664-25667.
28. Franzoni L, Nicastro G, Pertinhez TA, Oliveira E, Nakaie CR, Paiva AC, Schreier S & Spisni S 1999 Structure of two fragments of the third cytoplasmic loop of the rat angiotensin II AT1A receptor. Journal of Biological Chemistry 274 227-235. (doi:10.1074/jbc.274.1.227)
29. Fujino M, Miura S, Kiya Y, Tominaga Y, Matsuo Y, Karnik SS & Saku K 2010 A small difference in the molecular structure of AT1 receptor blockers induces AT1 receptor-dependent and-independent beneficial effects. Hypertension Research 33 1044-1052. (doi:10.1038/hr.2010.135)
30. Gaborik Z, Mihalik B, Jayadev S, Jagadeesh G, Catt KJ & Hunyady L 1998 Requirement of membrane-proximal amino acids in the carboxylterminal tail for expression of the rat AT1a angiotensin receptor. FEBS Letters 428 147-151. (doi:10.1016/S0014-5793(98)00511-0)
31. Gaborik Z, Jagadeesh G, Zhang M, Spat A, Catt KJ & Hunyady L 2003 The role of a conserved region of the second intracellular loop in AT1 angiotensin receptor activation and signaling. Endocrinology 144 2220-2228. (doi:10.1210/en.2002-0135)
32. de Gasparo M, Catt KJ, Inagami T, Wright JW & Unger T 2000 International union of pharmacology XXIII. The angiotensin II receptors. Pharmacological Reviews 52 415-472.
33. Groblewski T, Maigret B, Larguier R, Lombard C, Bonnafous JC & Marie J 1997 Mutation of Asn111 in the third transmembrane domain of the AT1A angiotensin II receptor induces its constitutive activation. Journal of Biological Chemistry 272 1822-1826. (doi:10.1074/jbc.272.3.1822)
34. Haendeler J, Ishida M, Hunyady L & Berk BC 2000 The third cytoplasmic loop of the angiotensin II type 1 receptor exerts differential effects on extracellular signal-regulated kinase (ERK1/ERK2) and apoptosis via Ras-and Rap1-dependent pathways. Circulation Research 86 729-736. (doi:10.1161/01.RES.86.7.729)
35. Hahn AW, Jonas U, Buehler FR & Resink TJ 1993 Identification of a fourth angiotensin AT1 receptor subtype in rat. Biochemical and Biophysical Research Communications 192 1260-1265.
36. Han HM, Shimuta SI, Kanashiro CA, Oliveira L, Han SW & Paiva AC 1998 Residues Val254, His256, and Phe259 of the angiotensin II AT1 receptor are not involved in ligand binding but participate in signal transduction. Molecular Endocrinology 12 810-814. (doi:10.1210/mend.12.6.0127)
37. Hines J, Fluharty SJ & Yee DK 2003 Structural determinants for the activation mechanism of the angiotensin II type 1 receptor differ for phosphoinositide hydrolysis and mitogen-activated protein kinase pathways. Biochemical Pharmacology 66 251-262. (doi:10.1016/S0006-2952(03)00257-0)
38. Hjorth AS, Schambye HT, Greenlee WJ & Schwartz TW 1994 Identification of peptide binding residues in the extracellular domains of the AT1 receptor. Journal of Biological Chemistry 269 30953-30959.
39. Holloway AC, Qian H, Pipolo L, Ziogas J, Miura S, Karnik S, Southwell BR, Lew MJ & Thomas WG 2002 Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors. Molecular Pharmacology 61 768-777. (doi:10.1124/mol.61.4.768)
40. Hunyady L & Catt KJ 2006 Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Molecular Endocrinology 20 953-970. (doi:10.1210/me.2004-0536)
41. Hunyady L, Bor M, Balla T & Catt KJ 1994 Identification of a cytoplasmic Ser-Thr-Leu motif that determines agonist-induced internalization of the AT1 angiotensin receptor. Journal of Biological Chemistry 269 31378-31382.
42. Hunyady L, Bor M, Baukal AJ, Balla T & Catt KJ 1995a A conserved NPLFY sequence contributes to agonist binding and signal transduction but is not an internalization signal for the type 1 angiotensin II receptor. Journal of Biological Chemistry 270 16602-16609. (doi:10.1074/jbc.270.28.16602)
43. Hunyady L, Bor M, Balla T & Catt KJ 1995b Critical role of conserved intramembrane tyrosine residue in angiotensin II receptor activation. Journal of Biological Chemistry 270 9702-9705. (doi:10.1074/jbc.270.28.16602)
44. Hunyady L, Balla T & Catt KJ 1996a The ligand binding site of the angiotensin AT1 receptor. Trends in Pharmacological Sciences 17 135-140. (doi:10.1016/0165-6147(96)81588-4)
45. Hunyady L, Zhang M, Jagadeesh G, Bor M, Balla T & Catt KJ 1996b Dependence of agonist activation on a conserved apolar residue in the third intracellular loop of the AT1 angiotensin receptor. PNAS 93 10040-10045. (doi:10.1073/pnas.93.19.10040)
46. Hunyady L, Ji H, Jagadeesh G, Zhang M, Gaborik Z, Mihalik B & Catt KJ 1998 Dependence of AT1 angiotensin receptor function on adjacent asparagine residues in the seventh transmembrane helix. Molecular Pharmacology 54 427-434.
47. Hunyady L, Gaborik Z, Shah B, Jagadeesh G, Clark AJ & Catt KJ 2004 Structural determinants of agonist-induced signaling and regulation of the angiotensin AT1 receptor. Molecular and Cellular Endocrinology 217 89-100. (doi:10.1016/j.mce.2003.10.014)
48. Imaizumi S, Miura S, Yahiro E, Uehara Y, Komuro I & Saku K 2013 Class-and molecule-specific differential effects of angiotensin II type 1 receptor blockers. Current Pharmaceutical Design 19 3002-3008. (doi:10.2174/1381612811319170005)
49. Inoue Y, Nakamura N & Inagami T 1997 A review of mutagenesis studies of angiotensin II type 1 receptor, the three-dimensional receptor model in search of the agonist and antagonist binding site and the hypothesis of a receptor activation mechanism. Journal of Hypertension 15 703-714. (doi:10.1097/00004872-199715070-00001)
50. Jagadeesh G 1998 Angiotensin II receptors-antagonists, molecular biology, and signal transduction. Indian Journal of Experimental Biology 36 1171-1194.
51. Jayadev S, Smith RD, Jagadeesh G, Baukal AJ, Hunyady L & Catt KJ 1999 N-linked glycosylation is required for optimal AT1a angiotensin receptor expression in Cos-7 cells. Endocrinology 140 2010-2017. (doi:10.1210/endo.140.5.6689)
52. Ji H, Leung M, Zhang Y, Catt KJ & Sandberg KJ 1994 Differential structural requirements for specific binding of nonpeptide and peptide antagonists to the AT1 angiotensin receptor. Identification of amino acid residues that determine binding of the antihypertensive drug losartan. Journal of Biological Chemistry 269 16533-16536.
53. Kai H, Alexander RW, Ushio-Fukai M, Lyons PR, Akers M & Griendling KK 1998 G-protein binding domains of the angiotensin II AT1A receptors mapped with synthetic peptides selected from the receptor sequence. Biochemical Journal 332 781-787.
54. Kakuta H, Kurosaki E, Niimi T, Gato K, Kawasaki Y, Suwa A, Honbou K, Yamaguchi T, Okumura H, Sanagi M et al. 2014 Distinct properties of telmisartan on agonistic activities for peroxisome proliferator-activated receptor g among clinically used angiotensin II receptor blockers: drug-target interaction analyses. Journal of Pharmacology and Experimental Therapeutics 349 10-20. (doi:10.1124/jpet.113.211722)
55. Karnik SS 2000 Conformational theories on receptor activation from studies of the AT1 receptor. In Drugs, Enzymes and Receptors of the Renin-Angiotensin System: Celebrating A Century of Discovery, pp 117-130. Eds A Husain & RM Graham. The Netherlands: Harwood Academic Publishers.
56. Karnik SS, Gogonea C, Patil S, Saad Y & Takezako T 2003 Activation of G-protein-coupled receptors: a common molecular mechanism. Trends in Endocrinology and Metabolism 14 431-437. (doi:10.1016/j.tem.2003.09.007)
57. Klco JM, Nikiforovich GV & Baranski TJ 2006 Genetic analysis of the first and third extracellular loops of the C5a receptor reveals an essential WXFG motif in the first loop. Journal of Biological Chemistry 281 12010-12019. (doi:10.1074/jbc.M600548200)
58. Kobilka BK 2000 Commentary: Conformational theories on receptor activation from studies of the AT1 receptor. In Drugs, Enzymes and Receptors of the Renin-Angiotensin System: Celebrating A Century of Discovery, pp 131-135. Eds A Husain & RM Graham. The Netherlands: Harwood Academic Publishers.
59. Kobilka BK & Deupi X 2007 Conformational complexity of G-proteincoupled receptors. Trends in Pharmacological Sciences 28 397-406. (doi:10.1016/j.tips.2007.06.003)
60. Laporte SA, Servant G, Richard DE, Escher E, Guillemette G & Leduc R 1996 The tyrosine within the NPXnY motif of the human angiotensin II type 1 receptor is involved in mediating signal transduction but is not essential for internalization. Molecular Pharmacology 49 89-95.
61. Marie J, Maigret B, Joseph MP, Larguier R, Nouet S, Lombard C & Bonnafous JC 1994 Tyr292 in the seventh transmembrane domain of the AT1A angiotensin II receptor is essential for its coupling to phospholipase C. Journal of Biological Chemistry 269 20815-20818.
62. Marion S, Oakley RH, Kim KM, Caron MG & Barak LS 2006 A b-arrestin binding determinant common to the second intracellular loops of rhodopsin family G protein-coupled receptors. Journal of Biological Chemistry 281 2932-2938. (doi:10.1074/jbc.M508074200)
63. Martin SS, Boucard AA, Clément M, Escher E, Leduc R & Guillemette G 2004 Analysis of the third transmembrane domain of the human type 1 angiotensin II receptor by cysteine scanning mutagenesis. Journal of Biological Chemistry 279 51415-51423. (doi:10.1074/jbc.M407965200)
64. Miura S & Karnik SS 2002 Constitutive activation of angiotensin II type 1 receptor alters the orientation of transmembrane helix-2. Journal of Biological Chemistry 277 24299-24305. (doi:10.1074/jbc.M202743200)
65. Miura S, Feng YH, Husain A & Karnik SS 1999 Role of aromaticity of agonist switches of angiotensin II in the activation of the AT1 receptor. Journal of Biological Chemistry 274 7103-7110. (doi:10.1074/jbc.274.11.7103)
66. Miura S, Zhang J, Boros J & Karnik SS 2003 TM2-TM7 interaction in coupling movement of transmembrane helices to activation of the angiotensin II type-1 receptor. Journal of Biological Chemistry 278 3720-3725. (doi:10.1074/jbc.M211338200)
67. Miura S, Kiya Y, Kanazawa T, Imaizumi S, Fujino M, Matsuo Y, Karnik SS & Saku K 2008 Differential bonding interactions of inverse agonists of angiotensin II type 1 receptor in stabilizing the inactive state. Molecular Endocrinology 22 139-146. (doi:10.1210/me.2007-0312)
68. Miura S, Kiya Y, Hanzawa H, Nakao N, Fujino M, Imaizumi S, Matsuo Y, Yanagisawa H, Koike H, Komuro I et al. 2012a Small molecules with similar structures exhibit agonist, neutral antagonist or inverse agonist activity toward angiotensin II type 1 receptor. PLoS ONE 7 e37974. (doi:10.1371/journal.pone.0037974)
69. Miura S, Okabe A, Matsuo Y, Karnik SS & Saku K 2012b Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan. Hypertension Research 36 134-139. (doi:10.1038/hr.2012.147)
70. Miura S-I, Nakao N, Hanzawa H, Matsuo Y, Saku K & Karnik SS 2013 Reassessment of the unique mode of binding between angiotensin II type 1 receptor and their blockers. PLoS ONE 8 e79914. (doi:10.1371/journal.pone.0079914)
71. Miura S, Matsuo Y, Nakayama A, Tomita S, Suematsu Y & Saku K 2014 Ability of the new AT1 receptor blocker azilsartan to block angiotensin II-induced AT1 receptor activation after wash-out. Journal of the Renin-Angiotensin-Aldosterone System 15 7-12.
72. Monnot C, Bihoreau C, Conchon S, Curnow KM, Corvol P & Clauser E 1996 Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Journal of Biological Chemistry 271 1507-1513. (doi:10.1074/jbc.271.3.1507)
73. Moukhametzianov R, Warne T, Edwards PC, Serrano-Vega MJ, Leslie AG, Tate CG & Schertler GF 2011 Two distinct conformations of helix 6 observed in antagonist-bound structures of a b1-adrenergic receptor. PNAS 108 8228-8232. (doi:10.1073/pnas.1100185108)
74. Nicastro G, Peri F, Franzoni L, Chiara CD, Sartor G & Spisni A 2003 Conformational features of a synthetic model of the first extracellular loop of the angiotensin II AT1A receptor. Journal of Peptide Science 9 229-243. (doi:10.1002/psc.449)
75. Nikiforovich GV & Marshall GR 2001 3D model for TM region of the AT-1 receptor in complex with angiotensin II independently validated by site-directed mutagenesis data. Biochemical and Biophysical Research Communications 286 1204-1211. (doi:10.1006/bbrc.2001.5526)
76. Nikiforovich GV, Mihalik B, Catt KJ & Marshall GR 2005 Molecular mechanisms of constitutive activity: mutations at position 111 of the angiotensin AT receptor. Journal of Peptide Research 66 236-248. (doi:10.1111/j.1399-3011.2005.00293.x)
77. Nikiforovich GV, Zhang M, Yang Q, Jagadeesh G, Chen H-C, Hunyady L, Marshall GR & Catt KJ 2006 Interactions between conserved residues in transmembrane helices 2 and 7 during angiotensin AT1 receptor activation. Chemical Biology & Drug Design 68 239-249. (doi:10.1111/j.1747-0285.2006.00444.x)
78. Noda K, Saad Y & Karnik SS 1995a Interaction of Phe8 of angiotensin II with Lys199 and His256 of AT1 receptor in agonist activation. Journal of Biological Chemistry 270 28511-28514. (doi:10.1074/jbc.270.48.28511)
79. Noda K, Saad Y, Kinoshita A, Boyle TP, Graham RM, Husain A & Karnik SS 1995b Tetrazole and carboxylate groups of angiotensin receptor antagonists bind to the same subsite by differentmechanisms. Journal of Biological Chemistry 270 2284-2289. (doi:10.1074/jbc.270.5.2284)
80. Noda K, Feng YH, Liu XP, Saad Y, Husain A & Karnik SS 1996 The active state of the AT1 angiotensin receptor is generated by angiotensin II induction. Biochemistry 35 16435-16442. (doi:10.1021/bi961593m)
81. Oakley RH, Laporte SA, Holt JA, Barak LS & Caron MG 2001 Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-b-arrestin complexes after receptor endocytosis. Journal of Biological Chemistry 276 19452-19460. (doi:10.1074/jbc.M101450200)
82. Ohno K, Amano Y, Kakuta K, Niimi T, Takakura S, Orita M, Miyata K, Sakashita H, Takeuchi M, Komuro I et al. 2011 Unique “delta lock” structure of telmisartan is involved in its strongest binding affinity to angiotensin II type 1 receptor. Biochemical and Biophysical Research Communications 404 434-437. (doi:10.1016/j.bbrc.2010.11.139)
83. Ohyama K, Yamano Y, Chaki S, Kondo T & Inagami T 1992 Domains for G-protein coupling in angiotensin II receptor type I: studies by site-directed mutagenesis. Biochemical and Biophysical Research Communications 189 677-683. (doi:10.1016/0006-291X(92)92254-U)
84. Ohyama K, Yamano Y, Sano T, Nakagomi Y, Hamakubo T, Morishima I & Inagami T 1995 Disulfide bridges in extracellular domains of angiotensin II receptor type IA. Regulatory Peptides 57 141-147. (doi:10.1016/0167-0115(95)00030-F)
85. Ohyama K, Yamano Y, Sano T, Nakagomi Y, Wada M & Inagami T 2002 Role of the conserved DRY motif on G protein activation of rat angiotensin II receptor type 1A. Biochemical and Biophysical Research Communications 292 362-367. (doi:10.1006/bbrc.2002.6670)
86. Olivares-Reyes JA, Smith RD, Hunyady L, Shah BH & Catt KJ 2001 Agonist-induced signaling, desensitization, and internalization of a phosphorylation-deficient AT1A angiotensin receptor. Journal of Biological Chemistry 276 37761-37768.
87. Oliveira L, Costa-Neto CM, Nakaie CR, Schreier S, Shimuta SI & Paiva AC 2007 The angiotensin II AT1 receptor structure-activity correlations in the light of rhodopsin structure. Physiological Reviews 87 565-592. (doi:10.1152/physrev.00040.2005)
88. Peeters MC, van Westen GJ, Li Q & IJzerman AP 2011 Importance of the extracellular loops in G protein-coupled receptors for ligand recognition and receptor activation. Trends in Pharmacological Sciences 32 35-42. (doi:10.1016/j.tips.2010.10.001)
89. Perlman S, Schambye HT, Rivero RA, Greenlee WJ, Hjorth SA & Schwartz TW 1995 Non-peptide angiotensin agonist. Journal of Biological Chemistry 270 1493-1496. (doi:10.1074/jbc.270.42.24682)
90. Perodin J, Deraet M, Auger-Messier M, Boucard AA, Rihakova L, Beaulieu ME, Lavigne P, Parent JL, Guillemette G, Leduc R et al. 2002 Residues 293 and 294 are ligand contact points of the human angiotensin type 1 receptor. Biochemistry 41 14348-14356. (doi:10.1021/bi0258602)
91. Petrel C & Clauser E 2009 Angiotensin II AT1 receptor constitutive activation: from molecular mechanisms to pathophysiology. Molecular and Cellular Endocrinology 302 176-184. (doi:10.1016/j.mce.2008.10.049)
92. Pignatari GC, Rozenfeld R, Ferro ES, Oliveira L, Paiva AC & Devi LA 2006 A role for transmembrane domains V and VI in ligand binding and maturation of the angiotensin II AT1 receptor. Biological Chemistry 387 269-276. (doi:10.1515/BC.2006.036)
93. Qian H, Pipolo L & Thomas WG 1999 Identification of protein kinase C phosphorylation sites in the angiotensin II (AT1A) receptor. Biochemical Journal 343 637-644. (doi:10.1042/0264-6021:3430637)
94. Qian H, Pipolo L & Thomas WG 2001 Association of b-arrestin 1 with the type 1A angiotensin II receptor involves phosphorylation of the receptor carboxyl terminus and correlates with receptor internalization. Molecular Endocrinology 15 1706-1719.
95. Rakugi H, Enya K, Sugiura K & Ikeda Y 2012 Comparison of the efficacy and safety of azilsartan with that of candesartan cilexetil in Japanese patients with grade I-II essential hypertension: a randomized, double-blind clinical study. Hypertension Research 35 552-558. (doi:10.1038/hr.2012.8)
96. Sano T, Ohyama K, Yamano Y, Nakagomi Y, Nakazawa S, Kikyo M, Shirai H, Blank JS, Exton JH & Inagami T 1997 A domain for G protein coupling in carboxyl-terminal tail of rat angiotensin II receptor type 1A. Journal of Biological Chemistry 272 23631-23636. (doi:10.1074/jbc.272.38.23631)
97. Santos EL, Pesquero JB, Oliveira L, Paiva AC & Costa-Neto CM 2004 Mutagenesis of the AT1 receptor reveals different binding modes of angiotensin II and [Sar1]-angiotensin II. Regulatory Peptides 119 183-188. (doi:10.1016/j.regpep.2004.02.009)
98. Satou R & Gonzalez-Villalobos RA 2012 JAK-STAT and the renin-angiotensin system. The role of the JAK-STAT pathway in blood pressure and intrarenal renin-angiotensin system regulation. JAK-STAT 1 250-256.
99. Schambye HT, Hjorth SA, Bergsma DJ, Sathe G & Schwartz TW 1994 Differentiation between binding sites for angiotensin II and nonpeptide antagonists on the angiotensin II type 1 receptors. PNAS 91 7046-7050. (doi:10.1073/pnas.91.15.7046)
100. Schambye HT, Hjorth SA, Weinstock J & Schwartz TW 1995 Interaction between the nonpeptide angiotensin antagonist SKF-108,566 and histidine 256 (HisVI:16) of the angiotensin type 1 receptor. Molecular Pharmacology 47 425-431.
101. Seta K & Sadoshima J 2003 Phosphorylation of tyrosine 319 of the angiotensin II type 1 receptor mediates angiotensin II-induced trans-activation of the epidermal growth factor receptor. Journal of Biological Chemistry 278 9019-9026. (doi:10.1074/jbc.M208017200)
102. Seta K, Nanamori M, Modrall JG, Neubig RR & Sadoshima J 2002 AT1 receptor mutant lacking heterotrimeric G protein coupling activates the Src-Ras-ERK pathway without nuclear translocation of ERKs. Journal of Biological Chemistry 277 9268-9277. (doi:10.1074/jbc.M109221200)
103. Shukla AK 2014 Biasing GPCR signaling from inside. Science Signaling 7 pe3. (doi:10.1126/scisignal.2005021)
104. Smit MJ, Vischer HF, Bakker RA, Jongejan A, Timmerman H, Pardo L & Leurs R 2007 Pharmacogenomic and structural analysis of constitutive G protein-coupled receptor activity. Annual Review of Pharmacology and Toxicology 47 53-87. (doi:10.1146/annurev.pharmtox.47.120505.105126)
105. Sokkar P, Mohandass S & Ramachandran M 2011 Multiple templatesbased homology modeling enhances structure quality of AT1 receptor: validation by molecular dynamics and antagonist docking. Journal of Molecular Modeling 17 1565-1577. (doi:10.1007/s00894-010-0860-z)
106. Szalai B, Barkai L, Turu G, Szidonya L, Varnai P& Hunyady L 2012 Allosteric interactions within the AT1 angiotensin receptor homodimer: role of the conserved DRY motif. Biochemical Pharmacology 84 477-485. (doi:10.1016/j.bcp.2012.04.014)
107. Thomas WG, Motel TJ, Kule CE, Karoor V & Baker KM 1998 Phosphorylation of the angiotensin II (AT1A) receptor carboxyl terminus: a role in receptor endocytosis. Molecular Endocrinology 12 1513-1524. (doi:10.1210/mend.12.10.0179)
108. Tuccinardi T, Calderone V, Rapposelli S & Martinelli A 2006 Proposal of a new binding orientation for non-peptide AT1 antagonists: homology modeling, docking and three-dimensional quantitative structure-activity relationship analysis. Journal of Medicinal Chemistry 49 4305-4316. (doi:10.1021/jm060338p)
109. Tzakos AG, Gerothanassis IP & Troganis AN 2004 On the structural basis of the hypertensive properties of angiotensin II: a solved mystery or a controversial issue? Current Topics in Medicinal Chemistry 4 431-444. (doi:10.2174/1568026043451375)
110. Unal H, Jagannathan R, Bhat MB & Karnik SS 2010 Ligand-specific conformation of the extracellular loop-2 in angiotensin II type 1 receptor. Journal of Biological Chemistry 285 16341-16350. (doi:10.1074/jbc.M109.094870)
111. Venema RC, Ju H, Venema VJ, Schieffer B, Harp JB, Ling BN, Eaton DC & Marrero MB 1998 Angiotensin II-induced association of phospholipase C-g1 with the G-protein-coupled AT1 receptor. Journal of Biological Chemistry 273 7703-7708. (doi:10.1074/jbc.273.13.7703)
112. Violin JD, DeWire SM, Yamashita D, Rominger DH, Nguyen L, Schiller K, Whalen EJ, Gowen M & LarkMW2010 Selectively engaging b-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance. Journal of Pharmacology and Experimental Therapeutics 335 572-579. (doi:10.1124/jpet.110.173005)
113. Vukelic S & Griendling KK 2014 Angiotensin II, from vasoconstrictor to growth factor a paradigm shift. Circulation Research 114 754-757. (doi:10.1161/CIRCRESAHA.114.303045)
114. Wei H, Ahn S, Shenoy SK, Karnik SS, Hunyady L, Luttrell LM & Lefkowitz RJ 2003 Independent b-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. PNAS 100 10782-10787. (doi:10.1073/pnas.1834556100)
115. Wei H, Ahn S, Barnes WG & Lefkowitz RJ 2004 Stable interaction between b-arrestin 2 and angiotensin type 1A receptor is required for b-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2. Journal of Biological Chemistry 279 48255-48261. (doi:10.1074/jbc.M406205200)
116. Wienen W, Entzeroth M, van Meel JC, Stangier J, Busch U, Ebner T, Schmid J, Lehmann H, Matzek K, Kempthorne-Rawson J et al. 2000 A review of telmisartan: a novel, long acting angiotensin II-receptor antagonist. Cardiovascular Drug Reviews 18 127-154. (doi:10.1111/j.1527-3466.2000.tb00039.x)
117. Wilkes BC, Masaro L, Schiller PW & Carpenter KA 2002 Angiotensin II vs its type I antagonists: conformational requirements for receptor binding assessed from NMR spectroscopic and receptor docking experiments. Journal of Medicinal Chemistry 45 4410-4418. (doi:10.1021/jm0103155)
118. Wilson PC, Lee M-H, Appleton KM, El-Shewy HM, Morinelli TA, Peterson YK, Luttrell LM & Jaffa AA 2013 The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers. Journal of Biological Chemistry 288 18872-18884. (doi:10.1074/jbc.M113.472381)
119. Yamano Y, Ohyama K, Chaki S, Guo D-F & Inagami T 1992 Identification of amino acid residues of rat angiotensin II receptor for ligand binding by site directed mutagenesis. Biochemical and Biophysical Research Communications 187 1426-1431. (doi:10.1016/0006-291X(92)90461-S)
120. Yamano Y, Ohyama K, Kikyo M, Sano T, Nakagomi Y, Inoue Y, Nakamura N, Morishima I, Guo D-F, Hamakubo T et al. 1995 Mutagenesis and the molecular modeling of the rat angiotensin II receptor (AT1). Journal of Biological Chemistry 270 14024-14030. (doi:10.1074/jbc.270.23.14024)
121. Yee DK, Suzuki A, Luo L & Fluharty SJ 2006 Identification of structural determinants for G protein-independent activation of mitogenactivated protein kinases in the seventh transmembrane domain of the angiotensin II type 1 receptor. Molecular Endocrinology 20 1924-1934. (doi:10.1210/me.2006-0018)
122. Zhang M, Zhao X, Chen HC & Catt KJ 1998 Dependence of AT1 angiotensin receptor function on adjacent asparagine residues in the seventh transmembrane helix. Molecular Pharmacology 54 427-434.
123. Zídek V, Mlejnek P, Šimáková M, Šilhavý J, Landa V, Kazdová L, Pravenec M & Kurtz TW 2013 Tissue-specific peroxisome proliferator activated receptor g expression and metabolic effects of telmisartan. American Journal of Hypertension 26 829-835. (doi:10.1093/ajh/hpt019)
124. Zimmerman B, Beautrait A, Aguila B, Charles R, Escher E, Claing A, Bouvier M & Laporte SA 2012 Differential b-arrestin-dependent conformational signaling and cellular responses revealed by angiotensin analogs. Science Signaling 5 ra33. (doi:10.1126/scisignal.2002522)